StudyFinds on MSN3h
New light-activated salt treatment targets aggressive breast cancer with precision
Photodynamic therapy shows promise in eliminating tumors in a mouse model RIVERSIDE, Calif. — In the ongoing battle against ...
Doctors enroll patients in trial for aggressive blood cancer
Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...
FDA approves new ADCETRIS regimen for lymphoma treatment
NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with $63.6 billion in annual revenue and an impressive 74% gross profit margin, has announced the U.S. Food and Drug Administration's ...